Managed care
Icare Health Solutions LLC
Icare Health Solutions LLC was paid $80.24M by Medicaid between Oct 2018 and Dec 2024, across 103 billing codes. Its largest line is 92004, Ophthalmological services: medical examination and evaluation, comprehensive, new patient — 24% of everything it billed.
33Billing provider infoICARE HEALTH SOLUTIONS LLC
MIAMI, FL 33122
MIAMI, FL 33122
33aNPI1942644661assigned 04/24/2013
33bProvider typeExclusive Provider Organization
28Total paid$80.24M
24GClaims2,160,935
24DCodes billed103
24AFirst – last monthOct 2018 – Dec 2024
Compared with peers
Next to other Exclusive Provider Organization providers in Florida
Rank by total paid#1 of 16
Median peer was paid$18K
This provider vs. median4,530×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 4,076 | $145K | |
| 2019 | 105,523 | $3.63M | |
| 2020 | 82,351 | $3.85M | |
| 2021 | 300,370 | $13.64M | |
| 2022 | 610,338 | $22.99M | |
| 2023 | 639,547 | $20.90M | |
| 2024incomplete | 418,730 | $15.09M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | 24% | 275,804 | 245,968 | $19.26M |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | 21% | 316,679 | 277,653 | $16.61M |
| V2100 | Sphere, single vision, plano to plus or minus 4.00, per lens | 19% | 296,473 | 246,941 | $14.86M |
| V2025 | Deluxe frame | 13% | 217,274 | 185,480 | $10.11M |
| V2020 | Frames, purchases | 11% | 271,730 | 235,278 | $8.57M |
| V2200 | Sphere, bifocal, plano to plus or minus 4.00d, per lens | 2.4% | 25,900 | 23,582 | $1.93M |
| V2799 | Vision item or service, miscellaneous | 2.2% | 86,882 | 52,309 | $1.74M |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | 1.9% | 24,486 | 20,625 | $1.51M |
| V2103 | Spherocylinder, single vision, plano to plus or minus 4.00d sphere, .12 to 2.00d cylinder, per lens | 1.2% | 55,379 | 42,072 | $936K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 1.2% | 7,306 | 6,504 | $929K |
| V2203 | Spherocylinder, bifocal, plano to plus or minus 4.00d sphere, .12 to 2.00d cylinder, per lens | <1% | 7,822 | 6,697 | $384K |
| V2784 | Lens, polycarbonate or equal, any index, per lens | <1% | 65,911 | 56,174 | $371K |
91 more codes
| 92015 | Determination of refractive state | <1% | 264,978 | $307K |
| 92060 | <1% | 14,749 | $277K | |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 5,822 | $264K |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 3,814 | $252K |
| 92340 | Fitting of spectacles, except for aphakia; monofocal | <1% | 69,175 | $168K |
| 67028 | Intravitreal injection of a pharmacologic agent | <1% | 1,950 | $155K |
| 99244 | Office or other outpatient consultation, moderate to high complexity | <1% | 594 | $113K |
| 92250 | <1% | 18,364 | $110K | |
| 92083 | <1% | 5,971 | $108K | |
| V2101 | Sphere, single vision, plus or minus 4.12 to plus or minus 7.00d, per lens | <1% | 1,512 | $86K |
| 99243 | <1% | 619 | $81K | |
| 92134 | <1% | 7,678 | $81K | |
| 92283 | <1% | 7,474 | $79K | |
| 92273 | <1% | 729 | $77K | |
| 76512 | <1% | 5,801 | $74K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 558 | $59K |
| V2599 | Contact lens, other type | <1% | 594 | $54K |
| 92341 | <1% | 9,906 | $49K | |
| 92235 | <1% | 720 | $49K | |
| V2201 | Sphere, bifocal, plus or minus 4.12 to plus or minus 7.00d, per lens | <1% | 620 | $47K |
| S0516 | Safety eyeglass frames | <1% | 280 | $47K |
| V2750 | Anti-reflective coating, per lens | <1% | 24,461 | $44K |
| 99233 | Hospital visit by a doctor, follow-up day (complex) | <1% | 290 | $44K |
| 66984 | Extracapsular cataract removal with insertion of intraocular lens prosthesis | <1% | 150 | $41K |
| V2781 | Progressive lens, per lens | <1% | 234 | $39K |
| 92100 | <1% | 412 | $36K | |
| 92133 | <1% | 3,722 | $27K | |
| 92285 | <1% | 8,033 | $27K | |
| V2744 | Tint, photochromatic, per lens | <1% | 998 | $26K |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 336 | $18K |
| 92025 | <1% | 2,567 | $16K | |
| 92286 | <1% | 3,092 | $15K | |
| V2520 | Contact lens, hydrophilic, spherical, per lens | <1% | 233 | $14K |
| V2104 | Spherocylinder, single vision, plano to plus or minus 4.00d sphere, 2.12 to 4.00d cylinder, per lens | <1% | 2,234 | $12K |
| V2745 | Addition to lens; tint, any color, solid, gradient or equal, excludes photochromatic, any lens material, per lens | <1% | 314 | $10K |
| V2303 | Spherocylinder, trifocal, plano to plus or minus 4.00d sphere, .12-2.00d cylinder, per lens | <1% | 54 | $9K |
| 92201 | <1% | 3,350 | $8K | |
| 92310 | <1% | 3,094 | $8K | |
| V2502 | Contact lens, pmma, bifocal, per lens | <1% | 172 | $8K |
| 92136 | <1% | 165 | $8K | |
| 92228 | <1% | 2,233 | $7K | |
| 92002 | <1% | 35 | $6K | |
| V2300 | Sphere, trifocal, plano to plus or minus 4.00d, per lens | <1% | 69 | $6K |
| 66761 | <1% | 34 | $6K | |
| 92227 | <1% | 1,193 | $5K | |
| J9035 | Injection, bevacizumab, 10 mg | <1% | 96 | $5K |
| S0595 | Dispensing new spectacle lenses for patient supplied frame | <1% | 758 | $4K |
| 76514 | <1% | 2,694 | $4K | |
| 92342 | <1% | 300 | $4K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 138 | $3K |
| V2755 | U-v lens, per lens | <1% | 2,398 | $3K |
| V2521 | Contact lens, hydrophilic, toric, or prism ballast, per lens | <1% | 44 | $3K |
| 99223 | Prolong inpt eval add15 m | <1% | 13 | $3K |
| 2022F | <1% | 2,122 | $2K | |
| 92020 | <1% | 1,237 | $2K | |
| 92202 | <1% | 1,101 | $2K | |
| V2522 | Contact lens, hydrophilic, bifocal, per lens | <1% | 45 | $2K |
| V2105 | Spherocylinder, single vision, plano to plus or minus 4.00d sphere, 4.25 to 6.00d cylinder, per lens | <1% | 20 | $2K |
| J3490 | Unclassified drugs | <1% | 205 | $2K |
| G0117 | Glaucoma screening for high risk patients furnished by an optometrist or ophthalmologist | <1% | 57 | $1K |
| V2762 | Polarization, any lens material, per lens | <1% | 30 | $1K |
| V2107 | Spherocylinder, single vision, plus or minus 4.25 to plus or minus 7.00 sphere, .12 to 2.00d cylinder, per lens | <1% | 468 | $1K |
| 76519 | <1% | 47 | $671.70 | |
| V2760 | Scratch resistant coating, per lens | <1% | 1,282 | $610.00 |
| 1036F | <1% | 281 | $164.98 | |
| 99205 | Prolong outpt/office vis | <1% | 12 | $156.42 |
| 4040F | <1% | 624 | $126.28 | |
| 92226 | <1% | 385 | $36.26 | |
| 1159F | <1% | 569 | $35.00 | |
| G8428 | Current list of medications not documented as obtained, updated, or reviewed by the eligible clinician, reason not given | <1% | 107 | $22.76 |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | <1% | 833 | $8.47 |
| 1000F | <1% | 921 | $7.70 | |
| 5010F | <1% | 2,129 | $4.62 | |
| 2020F | <1% | 2,861 | $4.62 | |
| 99024 | <1% | 1,582 | $2.31 | |
| 2023F | <1% | 272 | $1.54 | |
| 1160F | 0% | 569 | $0.00 | |
| G8482 | Influenza immunization administered or previously received | 0% | 702 | $0.00 |
| 92225 | 0% | 422 | $0.00 | |
| 99072 | 0% | 728 | $0.00 | |
| G8785 | Blood pressure reading not documented, reason not given | 0% | 84 | $0.00 |
| G9905 | Patient not screened for tobacco use | 0% | 40 | $0.00 |
| 2025F | 0% | 12 | $0.00 | |
| G8397 | Dilated macular or fundus exam performed, including documentation of the presence or absence of macular edema and level of severity of retinopathy | 0% | 2,414 | $0.00 |
| G9903 | Patient screened for tobacco use and identified as a tobacco non-user | 0% | 934 | $0.00 |
| 1157F | 0% | 63 | $0.00 | |
| J7999 | Compounded drug, not otherwise classified | 0% | 96 | $0.00 |
| G9902 | Patient screened for tobacco use and identified as a tobacco user | 0% | 33 | $0.00 |
| 3072F | 0% | 107 | $0.00 | |
| G9908 | Patient identified as tobacco user did not receive tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling and/or pharmacotherapy) | 0% | 47 | $0.00 |
| V2783 | Lens, index greater than or equal to 1.66 plastic or greater than or equal to 1.80 glass, excludes polycarbonate, per lens | 0% | 24 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSTERN, SIDNEY (MANAGER)